Cognitive and psychomotor effects of three months of escitalopram treatment in elderly patients with major depressive disorder

被引:12
|
作者
Beheydt, Lieve Lia [1 ,2 ]
Schrijvers, Didier [1 ,2 ]
Docx, Lise [1 ,3 ]
Bouckaert, Filip [4 ]
Hulstijn, Wouter [1 ]
Sabbe, Bernard [1 ,2 ]
机构
[1] Univ Antwerp, CAPRI, B-2610 Antwerp, Belgium
[2] Hosp Psychiat, Univ Psychiat Ctr, Duffel, Belgium
[3] Hosp Psychiat, Broeders Alexianen, Boechout, Belgium
[4] Univ Psychiat Ctr KU Leuven, Kortenberg, Belgium
关键词
Major depression; Elderly; Psychomotor retardation; Cognitive; Escitalopram; Functional burden; EXECUTIVE DYSFUNCTION; DOUBLE-BLIND; SYMPTOMS; RETARDATION; PERFORMANCE; OLD;
D O I
10.1016/j.jad.2015.08.041
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Although psychomotor retardation (PR) and cognitive disfunctioning are essential symptoms of elderly depressed patients, the differential effect of treatment with an SSRI in the elderly on these symptoms has hardly got any attention in studies with objective experimental measures. Since effects appear relatively slower in elderly, this study evaluates the effect on cognitive and psychomotor functioning as compared to mood, on four points during a twelve week follow up of monotreatment with escitalopram. Method: 28 non-demented elderly unipolar depressive patients on 5-20 mg escitalopram were compared to 20 matched healthy elderly. All participants underwent a test battery containing clinical depression measures, cognitive measures of processing speed, executive function and memory, clinical ratings of PR, and objective computerized fine motor skill-tests at the start and after 2,6 and 12 weeks. Statistical analysis consisted of a General Linear Model (GLM) repeated measures multivariate analysis of variance of completers to compare the psychomotor and cognitive outcomes of the two groups. Results: Although, apart from the significant mood effect, no interaction effects were found for the psychomotor and cognitive tasks, the means in general show a trend of differential effects in cognitive and psychomotor functions, with smaller effects and delayed timeframes and with presence of subgroups compared to mood effects. Limitation: Longer follow up studies are necessary to evaluate differential long term effects. Conclusion: In elderly, moderate effects of SSRI treatment on mood precede slow or limited effects on cognition and psychomotor retardation. (c) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 50 条
  • [1] Escitalopram in the long-term treatment of major depressive disorder in elderly patients
    Kasper, Siegfried
    Lemming, Ole Michael
    de Swart, Hans
    NEUROPSYCHOBIOLOGY, 2006, 54 (03) : 152 - 159
  • [2] Escitalopram in the long-term treatment of major depressive disorder in elderly patients
    Kasper, S.
    Lemming, O. M.
    de Swart, H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S233 - S233
  • [3] Escitalopram: In the treatment of major depressive disorder in adolescent patients
    Yang L.P.H.
    Scott L.J.
    Pediatric Drugs, 2010, 12 (3) : 155 - 162
  • [4] Escitalopram in the treatment of diabetic patients with major depressive disorder
    Pollock, Bruce G.
    Bose, Anjana
    Gordon, John
    Li, Dayong
    Gandhi, Chetan
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S98 - S99
  • [5] Escitalopram for the treatment of major depressive disorder in youth
    Ahn, Joon-Ho
    Patkar, Ashwin A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (14) : 2235 - 2244
  • [6] Escitalopram and citalopram in the treatment of major depressive disorder
    Andersen, HF
    Lam, RW
    NORDIC JOURNAL OF PSYCHIATRY, 2005, 59 (05) : 404 - 405
  • [7] Escitalopram for treatment of major depressive disorder in adults
    Llorca, PM
    Brousse, G
    Schwan, R
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2005, 31 (04): : 490 - 501
  • [8] Response trajectories during escitalopram treatment of patients with major depressive disorder
    Nunez, John-Jose
    Liu, Yang S.
    Cao, Bo
    Frey, Benicio N.
    Ho, Keith
    Milev, Roumen
    Mueller, Daniel J.
    Rotzinger, Susan
    Soares, Claudio N.
    Taylor, Valerie H.
    Uher, Rudolf
    Kennedy, Sidney H.
    Lam, Raymond W.
    PSYCHIATRY RESEARCH, 2023, 327
  • [9] Escitalopram and citalopram in the treatment of outpatients with major depressive disorder
    Moore, N
    Verdoux, H
    Fantino, B
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S426 - S426
  • [10] Comparative efficacy of escitalopram in the treatment of major depressive disorder
    Ali, Mazen K.
    Lam, Raymond W.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 : 39 - 49